anmelden
EQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
Werte in diesem Artikel
|
EQS Preliminary announcement financial reports: SCHOTT Pharma AG & Co. KGaA
/ Preliminary announcement on the disclosure of financial statements
Werbung
SCHOTT Pharma AG & Co. KGaA hereby announces that the following financial reports shall be disclosed:
Report Type: Quarterly/ Interim statement within the 1st half-year Language: German Date of disclosure: February 11, 2026 Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen Language: English Date of disclosure: February 11, 2026 Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations Report Type: Quarterly/ Interim statement within the 2nd half-year Language: German Date of disclosure: August 12, 2026 Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen Language: English Date of disclosure: August 12, 2026 Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations
18.08.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | SCHOTT Pharma AG & Co. KGaA |
| Hattenbergstraße 10 | |
| 55122 Mainz | |
| Germany |
| End of News | EQS News Service |
|
|
2185076 18.08.2025 CET/CEST
Ausgewählte Hebelprodukte auf SCHOTT Pharma
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf SCHOTT Pharma
Der Hebel muss zwischen 2 und 20 liegen
